Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-17

Clinical Trial Update: Leucine, MTOR and Athero [NA]

View source ↗

Summary

The study NCT05470218 is an active-but-not-recruiting trial examining leucine and the mTOR pathway in atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leucine (Leucine)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Atherosclerosis | NA | Status: ACTIVE_NOT_RECRUITING